Location
London, X0
Holdings as of
9/30/2025
Date filed
11/12/2025
Form type
13F-HR
Num holdings
81
Total value ($000)
$808,571
Net value change ($000)
+29,317 (3.8%)
New positions
14
Sold out positions
11
Turnover %
116.1%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/19/2025 Next filing: 2/12/2026 SEC filing

Snapshot: Change Analysis

Compared to Q2 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
CYBR 23,831 NEW
KEL 18,701 329.2%
NSC 9,864 NEW
AMRZ 6,157 NEW
BCSS 5,053 NEW
AEXA 5,046 NEW
COMP 3,833 NEW
LLYVA 3,698 498.4%
DD 3,621 NEW
RAL 3,620 NEW
Top Reduces (Value $000, Stocks/ETFs)
AHC -28,557 -100.0%
AKX -19,178 -100.0%
DKS -16,333 -100.0%
Sage Therapeutics, Inc. -5,605 -100.0%
SKAA -5,054 -100.0%
SNDK -3,631 -100.0%
WOO -3,505 -100.0%
KDK -3,390 -100.0%
NV5 Global, Inc. -2,971 -100.0%
TRIP -2,257 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 891 (0.1% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type